Signed in as:

filler@godaddy.com

Account

Valacore Therapeutics

Pioneering next-generation therapies for neuropathic pain — A new standard in pharmaceutical excellence.

Valacore Therapeutics

Pioneering next-generation therapies for neuropathic pain — A new standard in pharmaceutical excellence.

It’s almost here!

Mirolith ™ Launch Alert!

The launch date for Mirolith ™ — India’s first brand of Mirogabalin Besylate tablets — is fast approaching!

Be among the first to access this groundbreaking treatment for neuropathic pain. Create your account and place your orders now!

⚠️ Important Notice:
This product is strictly intended for institutional supply to hospitals and hospital use only.

Retail sale is not permitted.

DaysDays

HrsHours

MinsMinutes

SecsSeconds

About Us

Commitment to Innovation

Valacore Therapeutics:

Valacore Therapeutics is a focused pharmaceutical company committed to revolutionizing neuropathic pain care through advanced, precise, and patient-centric therapies.

Our flagship initiative centers around Mirogabalin, a next-generation gabapentinoid designed to offer superior relief for conditions like diabetic neuropathy, fibromyalgia, and post-herpetic neuralgia. With higher binding selectivity and a reduced side-effect profile, Mirogabalin represents a breakthrough for patients who have struggled with traditional molecules like pregabalin or gabapentin.

At Valacore, we believe in:

Science with purpose — Every decision we make is driven by real-world needs and patient dignity.
Clinical integrity — All our formulations are designed with strict adherence to JP standards and GMP-certified processes.
Access and comfort — We are committed to ensuring that cutting-edge molecules like Mirogabalin are accessible to the institutions, hospitals, and professionals who need them most.

Our launch product, Mirolith 5 ™ (Mirogabalin 5mg), is formulated for hospital and clinical use, where quality, compliance, and reliability matter most.

Why Mirogabalin?

Higher Selectivity for α2δ-1 Subunit → Greater efficacy
Lower CNS Adverse Events → Better tolerability
Improved PK Profile → Flexible dosing and long-term usability
JP-standard Formulation → Global alignment and credibility

Our Mission

To make next-generation neurological relief accessible, effective, and trusted — starting with Mirogabalin.

Valacore Therapeutics

Pioneering next-generation therapies for neuropathic pain — A new standard in pharmaceutical excellence.

MIROLITH 5™

Product Launch Statement: Mirolith™

We’re proud to announce the launch of Mirolith ™ , our flagship formulation of Mirogabalin 5 mg tablets, developed to address neuropathic pain with clarity, precision, and control.

Formulated under strict quality standards and powered by Valacore’s research-driven mission, Mirolith delivers advanced relief from conditions such as diabetic neuropathy, post-herpetic neuralgia, and other chronic nerve-related disorders — with less sedation and more functional relief.

Mirolith 5 mg will be available across India through select distributor and pharmacy channels.

Each box contains 3 blister strips of 10 tablets and is manufactured in partnership with a GMP-certified CDMO under full quality control and stability assurance.

This is just the beginning. We’re not here to compete. We’re here to replace.
To reshape the way the world treats pain — with smarter drugs, cleaner outcomes, and real dignity.

The End of Pregabalin’s Era

Millions continue to depend on pregabalin, despite its well-known drawbacks: heavy sedation, brain fog, tolerance buildup, and inconsistent relief. At Valacore, we saw this not just as a medical gap — but as a global failure to evolve.

Mirolith 5 ™ is our answer. Developed from the cutting-edge molecule Mirogabalin, Mirolith ™ offers:

Sharper receptor selectivity
Faster onset of action
Minimal sedation and cognitive dulling
Powerful, targeted pain relief for neuropathic conditions

This is relief without compromise — clarity without sedation, calm without fog.

Changing the World, One Nerve at a Time

From diabetic neuropathy to fibromyalgia and post-herpetic neuralgia, nerve pain disrupts lives at every level — physically, mentally, emotionally.

Mirolith 5 ™ is more than a molecule — it’s a movement. A movement toward:

Staying functional while being pain-free
Sleeping peacefully without waking up groggy
Living fully, without dependency or dullness

For patients, caregivers, physicians — and even informed recreational users — Mirolith ™ marks the beginning of the end for outdated, side-effect-heavy molecules.

Learn More

Valacore Therapeutics
Science in Motion. Relief in Reach.

📨 info@valacorepharma.com
📍 India | Global B2B Enquiries Welcome
🔗 www.valacoretherapeutics.com

Find out more

OUR TEAM

CEO And Founder - Babu Rishikesh

Babu Rishikesh is the visionary force behind Valacore Therapeutics, leading the company’s mission to bring next-generation neurological and pain relief therapies to the forefront of Indian and global healthcare.

With over a decade of experience spanning pharmaceutical innovation, crypto finance, and international business development, Babu merges a rare mix of scientific insight and entrepreneurial courage.

He has contributed to over 45 global crypto projects, worked with 7 centralized cryptocurrency exchanges, and led high-impact strategies for multiple MNCs — always with integrity and disruptive vision.

Driven by deeply personal experiences with chronic health systems and neuropharmacology, Babu founded Valacore to challenge outdated industry norms and democratize access to powerful CNS molecules like Mirogabalin.

His commitment to transparency, regulatory navigation, and real-world therapeutic value defines Valacore’s ethos.

Under his leadership, the company is expanding rapidly, launching its flagship product Mirolith 5, and forging partnerships across India’s hospital and institutional supply networks.

Babu is also a certified Anti-Financial Crime & AML specialist, a national-level archer, and a passionate advocate for scientific reform, mental health access, and ethical pharmaceutical distribution.

Contact him at : babu.r@valcorepharma.com

Linkedin: https://www.linkedin.com/in/baburishikesh/

CTO and Co Founder - Rene "Duke"

Rene "Duke" is the silent architect behind Valacore Therapeutics’ scientific and strategic backbone. Operating primarily behind the scenes, Rene prefers anonymity, allowing his work — not his name — to speak volumes.

Based in Germany, Rene brings extensive expertise across a wide spectrum of pharmaceutical sciences, with deep knowledge in neurological compounds, controlled substances, and emerging therapeutics.

His meticulous research and global insight help guide Valacore’s formulation strategy, compliance approach, and API sourcing.

Driven by a personal and philosophical commitment to ending the global drug war, Rene is dedicated to transforming access to safe, effective, and stigma-free medications.

His role in Valacore is not just scientific, but deeply ideological — pushing back against outdated systems and advocating for patient autonomy through chemistry.

A quiet force with uncompromising standards, Rene ensures that every molecule Valacore touches upholds clinical relevance, bioethical integrity, and the freedom to heal.

Contact him at : rene.d@valcorepharma.com

PURCHASE DISCLAIMER

⚠️ Controlled Access – Institutional Purchase Only

Mirolith 5 ™ (Mirogabalin 5mg) is a prescription-grade formulation intended strictly for hospital use, institutional research, and controlled R&D applications. As part of our regulatory commitment and to maintain pharmacological integrity, Valacore Therapeutics does not permit open or over-the-counter sales of this product under any circumstance.

How to Apply for Purchase Authorization:

All product access is restricted to verified organizations and granted on a “may approve” basis following a thorough review of credentials. To request purchase authorization:

Register on our website using the “Create Account” option
Submit your institutional details during the application (including license documents, address, GST, and regulatory ID where applicable)
Our compliance team will evaluate your request
Upon approval, you will receive a secure username and password, which will allow you to access the ordering dashboard and track shipments

To Increase Your Chances of Approval:

To improve your application's likelihood of being accepted, please ensure:

You are a registered hospital, laboratory, CDMO, or licensed distributor
You provide a valid Drug License issued by the Government of India (Form 20B / 21B)
You submit complete and accurate documentation during registration
You agree to comply with Valacore’s restricted-use protocols and product labeling standards

Important Disclaimers

Mirolith 5 ™ is not to be sold to the general public or for retail use
It is not to be used for human consumption outside licensed medical environments
Unauthorized access, resale, or diversion of our products may result in blacklisting and legal action
All purchases are logged and may be subject to audit under CDSCO, State Drug Controller, and International Traceability Protocols

Valacore Therapeutics reserves the right to reject or revoke purchase access at its sole discretion, without prior notice.

For any assistance or to inquire about eligibility, please contact:
📧 compliance@valacorepharma.com

🏛️ Regulatory & Compliance Overview

Regulatory Overview

At Valacore Therapeutics, regulatory responsibility is at the core of everything we do. We are a dual-registered pharmaceutical research and formulations organization with operating bases in both India and the United States, actively engaged in R&D, pre-commercial development, and institutional-grade supply strategy.

Indian Operations – Formulations Division:

Valacore Therapeutics (India) operates from our formulation and R&D unit located in Madambakkam, Chennai, Tamil Nadu, with laboratory and small-scale batch capabilities. Our facility functions under:

Indian MSME Registration as a scientific and industrial research organization
Ongoing CDSCO (Central Drugs Standard Control Organisation) registration for R&D formulation and analytical work
Internal adherence to Schedule M standards for storage, documentation, and quality assurance (non-commercial use)
Strict internal SOPs for handling APIs, test batches, excipient integrity, and sample destruction protocols

Our GSTIN is currently under registration: 33MOKTR9208N1Z0

We are not engaged in direct human-use sales, clinical distribution, or retail pharmacy operations. All material handling is strictly for institutional, research, and test-scale work only.

U.S. Oversight – Valacore Research [USA]:

Valacore Research is our regulatory and oversight entity based in Denver, Colorado, United States, operating under the federal EIN: 83-1898746.

We oversee compliance alignment across:

U.S. FDA Good Laboratory Practices (GLP)
International Regulatory Harmonization
Documentation standards & material traceability audits
Long-term R&D planning for CNS-targeted therapeutics

Commitment to Transparency & Ethics:

We are fully committed to the legal, safe, and transparent use of all chemical substances and active pharmaceutical ingredients (APIs) handled by our organization. Valacore maintains documented audit trails, vendor compliance checks, and batch-level controls at all times.

Valacore does not engage in any activities that contravene India’s Drugs and Cosmetics Act or any equivalent international law.

Valacore Therapeutics — Formulating the Future with Purpose, Precision, and Legitimacy.

Valacore Therapeutics

Valacore Therapeutics

Valacore Therapeutics

It’s almost here!